Girihlet’s T and B cell sequencing assays and immune map database allow predictions and measurements on a person’s health status and provide an un understanding of the immune system in order to treat cancer, allergies, infections and autoimmune disease.
Timeline
August 2018
Girihlet raises a $2,500,000 seed round from Digitalis Ventures and True Ventures.
September 2015
Girihlet raises a $250,000 seed round from IndieBio and SOSV.
Funding rounds
People
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
References
Is a
CompanyCompany attributes
Biomedical engineering
Genetics
Autoimmune diseaseLocation
Brooklyn
Oakland, CaliforniaCrunchbase
Accelerator
IndieBioAccelerator Batch
Place of incorporation
United States
SOSV
True Ventures
Digitalis VenturesFounded date
2012
Total funding amount (USD)
2,750,000
Latest funding round date
August 2018
Latest funding type
Categories
Related Topics
Contributors
- 1
Jude Gomila
Founder and CEO of Golden, Entrepreneur. Investor in 200+ companies. Cantabrigian (Gonville and Caius). Interested in the Universe. - 2
Melanie Manipula
Helping organize knowledge. - 3
Meredith Hanel
Medical Genetics PhD, following life science applications that improve the health of humans and our planet. - 4
Alex Dean
Healthcare Research Analyst @ Veradigm | Masters in Biostatistics/Epidemiology: UC Berkeley | BA in Biology: Wesleyan University - 5
Amy Sar
Data acquisition - 6
Erin Scherfner
loading information... - 7
Aleksander Holm
Interested in understanding the world we live in. - 8
Henry Ogolla
Passionate about reading and writing.